Clinical trial
Oral Versus Intravenous Proton Pump Inhibitor Treatment in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis: a Prospective Randomized Comparative Study
NCT01182597 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Versus Intravenous Proton Pump Inhibitor Treatment in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis: a Prospective Randomized Comparative Study
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- August 31, 2010
- Completion date
- Not reported
- Enrollment
- 190 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
peptic ulcers